Almirall, S.A.: Psoriasis trials
The registry lists 20 Psoriasis studies with Almirall, S.A. as lead sponsor. 2 are open to participants now and 2 have results posted.
Phase 1 2Phase 2 7Phase 3 3Phase 4 3No phase 6(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- A Study to Assess the Effects of Switching From a Biologic Treatment to Tildrakizumab Using Patient-reported Outcomes in Adult Participants With Moderate to Severe Plaque PsoriasisRecruitingNCT06030076
- A Study of Tildrakizumab in the Treatment of Genital Psoriasis (CZATCH-Genital-PsO)RecruitingNCT06029257
- A Study to Assess Treatment Satisfaction, Patient-reported Outcomes, Effectiveness, and Safety of a Fixed-dose Combination of Calcipotriene/Betamethasone Dipropionate PAD Cream in the Treatment of Mild-to-moderate Plaque Psoriasis of the Scalp in AdultsCompletedNCT05811234Results posted
- Observational Study of Tildrakizumab in Patients With Moderate to Severe Plaque Psoriasis in Routine Clinical PracticeCompletedNCT04203693Results posted
- A Study to Assess Patient-Reported Wellbeing Using Tildrakizumab in a Live SettingActive, not recruitingNCT06488170
- Observational Real-world Evidence (RWE) Study to Assess Patient-reported Wellbeing Using Tildrakizumab in Live Setting - POSITIVE StudyCompletedNCT04823247
- Long-Term Treatment Effect With Tildrakizumab in Participants With Plaque PsoriasisTerminatedNCT04339595Phase 4
- Efficacy and Safety of Tildrakizumab in Participants With Moderate-to-Severe Chronic Plaque Psoriasis Who Are Non-Responders to Dimethyl Fumarate TherapyCompletedNCT04263610Phase 4
- Efficacy and Safety of Tildrakizumab 100 Milligrams (mg) in Participants With Moderate-Severe Chronic Plaque Psoriasis and Its Impact on Their Quality of Life (TRIBUTE)CompletedNCT04229836Phase 4
- Study to Evaluate the Efficacy and Safety of P-3073 Nail Solution in the Treatment of Mild to Moderate Psoriatic Fingernail/sWithdrawnNCT03079973Phase 3
- Study of the Effects of the Organism on Monomethyl Fumarate (MMF) After the Administration of LAS41008CompletedNCT02955693Phase 1
- Study to Evaluate the Efficacy and Safety of P-3073 Nail Solution in the Treatment of Nails Affected by PsoriasisCompletedNCT02606760Phase 3
- Efficacy and Safety of Tazarotene Gel in Nail PsoriasisCompletedNCT02235480Phase 2
- A Intra-individual Comparison to Investigate the Efficacy and the Safety of LAS41004 Formulation in Mild to Moderate PsoriasisCompletedNCT02180464Phase 2
- Efficacy, Tolerability and Safety of LAS41004 Formulations in a Psoriasis Plaque TestCompletedNCT02111499Phase 1/2
- LAS41008 in Moderate to Severe Chronic Plaque PsoriasisCompletedNCT01726933Phase 3
- Efficacy and Tolerability of LAS41004 Formulations in a Non-occlusive Psoriasis Plaque TestCompletedNCT01462643Phase 2
- Exploratory Study to Investigate Efficacy of LAS41004 in a Psoriasis Plaque TestCompletedNCT01360944Phase 2
- Clinical Trial to Investigate Efficacy of LAS41004 in PsoriasisCompletedNCT01283698Phase 2
- Study to Investigate Dose-related Efficacy of LAS41004 in the Treatment of PsoriasisCompletedNCT01119339Phase 2